J
J. Michael Swint
Researcher at University of Texas Health Science Center at Houston
Publications - 46
Citations - 2703
J. Michael Swint is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Medicine & Cost effectiveness. The author has an hindex of 12, co-authored 40 publications receiving 2303 citations. Previous affiliations of J. Michael Swint include University of Texas System & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L. Chang,Jeffrey S. Wefel,Kenneth R. Hess,Pamela K. Allen,Frederick F. Lang,David G. Kornguth,Rebecca Arbuckle,J. Michael Swint,Almon S. Shiu,Moshe H. Maor,Christina A. Meyers +10 more
TL;DR: Patients treated with SRS plus WBRT were at a greater risk of a significant decline in learning and memory function by 4 months compared with the group that received SRS alone, and patients treatment with a combination of SRS and close clinical monitoring was recommended as the preferred treatment strategy.
Journal ArticleDOI
Community-based participatory research to prevent substance abuse and HIV/AIDS in African-American adolescents.
Marianne T. Marcus,Thomas Walker,J. Michael Swint,Brenda Page Smith,Cleon Brown,Nancy H. Busen,Thelissa Edwards,Patricia Liehr,Wendell C. Taylor,Darryal Williams,Kirk von Sternberg +10 more
TL;DR: The results support the use of community-based participatory research to create desirable change in this setting and support the design, implement, and evaluate a faith-based substance abuse and HIV/AIDS prevention program for African-American adolescents.
Journal ArticleDOI
Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature
Hadley Stevens Smith,J. Michael Swint,Seema R. Lalani,Jose-Miguel Yamal,Marcia C de Oliveira Otto,Stephan Castellanos,A.M. Taylor,Brendan Lee,Heidi V. Russell +8 more
TL;DR: Reported CGS use has rapidly increased and spans diverse clinical settings and patient phenotypes andMultidisciplinary implementation research is needed to demonstrate clinical utility and cost-effectiveness of CGS.
Journal ArticleDOI
Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Ashish A. Deshmukh,Shervin M. Shirvani,Lincy S. Lal,J. Michael Swint,Scott B. Cantor,Benjamin Smith,Anna Likhacheva +6 more
TL;DR: For women with early-stage breast cancer requiring adjuvant radiotherapy, HF-W BI is cost-effective compared with CF-WBI and IORT and was most sensitive to the probability of metastasis and treatment cost.
Journal ArticleDOI
Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: A nested cohort study
Abhinav Khanna,Amber L. Bush,Amber L. Bush,J. Michael Swint,Melissa F. Peskin,Richard L. Street,Richard L. Street,Richard L. Street,Aanand D. Naik,Aanand D. Naik +9 more
TL;DR: Improvements in HbA1c among participants completing a diabetes self-management program were associated with better diabetes-specific quality of life, a key outcome from the patient perspective.